Search
Terikalant
go.drugbank.com/drugs/DB20720ExperimentalTerikalant is a small molecule drug. The usage of the INN stem '-kalant' in the name indicates that Terikalant is a potassium channel blocker.
Nivasorexant
go.drugbank.com/drugs/DB21506ExperimentalNivasorexant is a small molecule drug. The usage of the INN stem '-orexant' in the name indicates that Nivasorexant is a orexin receptor antagonist.
Dalmelitinib
go.drugbank.com/drugs/DB21538ExperimentalDalmelitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Dalmelitinib is a tyrosine kinase inhibitor.
Funobactam
go.drugbank.com/drugs/DB21541InvestigationalFunobactam is a small molecule drug. The usage of the INN stem '-bactam' in the name indicates that Funobactam is a ẞ-lactamase inhibitor. Funobactam has a monoisotopic molecular weight of 399.1 Da.
Atinvicitinib
go.drugbank.com/drugs/DB21558ExperimentalAtinvicitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Atinvicitinib is a Janus kinase inhibitor.
Xelaglifam
go.drugbank.com/drugs/DB21598InvestigationalXelaglifam is a small molecule drug. Xelaglifam is under investigation in clinical trial NCT04982705 (IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics).
Fulimetibant
go.drugbank.com/drugs/DB21599ExperimentalFulimetibant is a small molecule drug. The usage of the INN stem '-tibant' in the name indicates that Fulimetibant is a bradykinin receptor antagonist.
Adrixetinib
go.drugbank.com/drugs/DB21620InvestigationalAdrixetinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Adrixetinib is a tyrosine kinase inhibitor.
Friluglanstat
go.drugbank.com/drugs/DB21652ExperimentalFriluglanstat is a small molecule drug. The usage of the INN stem '-glanstat' in the name indicates that Friluglanstat is a prostaglandin synthase inhibitor.
Canlitinib
go.drugbank.com/drugs/DB21656ExperimentalCanlitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Canlitinib is a tyrosine kinase inhibitor.